Researchers Develop Customizable DNA Labels to Target Cancer Cells with Drug Carriers
Audio narration · Coming soon
Researchers at Carnegie Mellon University have created a simple and low-cost method to modify natural cellular packages into drug carriers that can selectively deliver treatments to cancer cells. This innovation aims to enhance treatment effectiveness while minimizing side effects. The development leverages the natural communication system of cells to improve targeted drug delivery.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews
